chr11-67991572-C-G

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_030930.4(UNC93B1):​c.1768G>C​(p.Gly590Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000329 in 1,488,814 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G590W) has been classified as Benign.

Frequency

Genomes: 𝑓 0.000039 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000032 ( 0 hom. )

Consequence

UNC93B1
NM_030930.4 missense

Scores

1
3
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.38

Publications

2 publications found
Variant links:
Genes affected
UNC93B1 (HGNC:13481): (unc-93 homolog B1, TLR signaling regulator) This gene encodes a protein that is involved in innate and adaptive immune response by regulating toll-like receptor signaling. The encoded protein traffics nucleotide sensing toll-like receptors to the endolysosome from the endoplasmic reticulum. Deficiency of the encoded protein has been associated with herpes simplex encephalitis. [provided by RefSeq, Feb 2014]
UNC93B1 Gene-Disease associations (from GenCC):
  • herpes simplex encephalitis, susceptibility to, 1
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.15880063).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
UNC93B1NM_030930.4 linkc.1768G>C p.Gly590Arg missense_variant Exon 11 of 11 ENST00000227471.7 NP_112192.2 Q9H1C4
UNC93B1XM_011545290.1 linkc.1357G>C p.Gly453Arg missense_variant Exon 9 of 9 XP_011543592.1
UNC93B1XM_011545291.3 linkc.1213G>C p.Gly405Arg missense_variant Exon 8 of 8 XP_011543593.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
UNC93B1ENST00000227471.7 linkc.1768G>C p.Gly590Arg missense_variant Exon 11 of 11 1 NM_030930.4 ENSP00000227471.3 Q9H1C4
UNC93B1ENST00000525368.1 linkn.*246G>C downstream_gene_variant 2

Frequencies

GnomAD3 genomes
AF:
0.0000395
AC:
6
AN:
151942
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000388
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000295
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000323
AC:
3
AN:
92742
AF XY:
0.0000386
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000564
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000168
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000272
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000322
AC:
43
AN:
1336872
Hom.:
0
Cov.:
30
AF XY:
0.0000349
AC XY:
23
AN XY:
658166
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
27010
American (AMR)
AF:
0.0000680
AC:
2
AN:
29424
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23130
East Asian (EAS)
AF:
0.0000942
AC:
3
AN:
31844
South Asian (SAS)
AF:
0.0000270
AC:
2
AN:
74010
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
33142
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3918
European-Non Finnish (NFE)
AF:
0.0000340
AC:
36
AN:
1058832
Other (OTH)
AF:
0.00
AC:
0
AN:
55562
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000395
AC:
6
AN:
151942
Hom.:
0
Cov.:
33
AF XY:
0.0000404
AC XY:
3
AN XY:
74220
show subpopulations
African (AFR)
AF:
0.0000483
AC:
2
AN:
41416
American (AMR)
AF:
0.00
AC:
0
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.000388
AC:
2
AN:
5150
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
312
European-Non Finnish (NFE)
AF:
0.0000295
AC:
2
AN:
67884
Other (OTH)
AF:
0.00
AC:
0
AN:
2086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000781
Hom.:
0
Bravo
AF:
0.0000453

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Herpes simplex encephalitis, susceptibility to, 1 Uncertain:1
Jul 30, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 590 of the UNC93B1 protein (p.Gly590Arg). This variant is present in population databases (no rsID available, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with UNC93B1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1052109). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.34
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.47
CADD
Benign
19
DANN
Uncertain
1.0
DEOGEN2
Benign
0.16
T
Eigen
Benign
-0.10
Eigen_PC
Benign
-0.22
FATHMM_MKL
Benign
0.38
N
LIST_S2
Benign
0.80
T
M_CAP
Benign
0.046
D
MetaRNN
Benign
0.16
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.4
L
PhyloP100
3.4
PrimateAI
Pathogenic
0.84
D
PROVEAN
Benign
-0.66
N
REVEL
Benign
0.11
Sift
Uncertain
0.023
D
Sift4G
Uncertain
0.057
T
Polyphen
1.0
D
Vest4
0.062
MutPred
0.43
Gain of solvent accessibility (P = 0.0037);
MVP
0.043
MPC
0.95
ClinPred
0.71
D
GERP RS
4.6
Varity_R
0.14
gMVP
0.42
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2375182; hg19: chr11-67759043; API